Parameter
| Biomarker | Pro-ADM | Full name | Proadrenomyelin | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognostic assessment and condition monitoring |
| Disease | pneumonia | Disease Subtypes | / | ||
| Organ | Lung | Test Sample / Technology Platform | Serum (immunoassay technology) | ||
| Pathobiological Mechanisms | Inflammation, hypoxia and endothelial damage caused by pneumonia induce a large amount of it, and the level is positively correlated with the extent of pulmonary inflammation and the intensity of systemic inflammatory response | ||||
| Clinical Availability Status | Clinical validation: used to assess risk of adverse outcomes | ||||
| Notes and Dynamics | The higher the level of admission, the higher the rate of mechanical ventilation and the mortality rate of hospitalization. Changes in treatment predict prognosis | ||||